Medicine and Dentistry
Radiation Therapy
100%
Non Small Cell Lung Cancer
78%
Overall Survival
39%
Stereotactic Body Radiation Therapy
33%
Lung
30%
Neoplasm
30%
Magnetic Resonance Imaging
26%
Lung Cancer
19%
Immune Checkpoint Inhibitor
19%
Chemoradiotherapy
18%
Pelvis
17%
Computer Assisted Tomography
16%
Prostate Cancer
14%
Non-Small Cell Lung Cancer
13%
Patient-Reported Outcome
12%
Chemotherapy
11%
Adaptive Radiotherapy
11%
Small Cell Lung Cancer
11%
Pancreas Cancer
11%
Adaptive Radiation
11%
Volume CT
11%
Disease
10%
Quality of Life
10%
Contouring
10%
Lymph Node
10%
Adverse Event
9%
Drug Megadose
8%
Randomized Controlled Trial
8%
Proportional Hazards Model
8%
Survival Rate
8%
Comorbidity
7%
Arm
7%
Oncology
7%
Immunotherapy
7%
Venous Thromboembolism
7%
Malignant Neoplasm
6%
Surgery
6%
Immunity
6%
Intensity Modulated Radiation Therapy
6%
Hazard Ratio
6%
Progression Free Survival
5%
Phase II Trials
5%
Brain Metastasis
5%
Clinical Trial
5%
Positron Emission Tomography-Computed Tomography
5%
Liver Metastasis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
70%
Overall Survival
47%
Neoplasm
29%
Lung Cancer
27%
Chemoradiation Therapy
22%
Immune Checkpoint Inhibitor
19%
Comorbidity
13%
Chemotherapy
12%
Malignant Neoplasm
11%
Immunotherapy
11%
Small Cell Lung Cancer
11%
Prostate Cancer
11%
Phase II Trials
9%
Survival Rate
9%
Brain Metastasis
9%
Disease
9%
Cohort Study
8%
Venous Thromboembolism
7%
Tolerability
7%
Pancreas Cancer
7%
Progression Free Survival
7%
Lung Tumor
6%
Adverse Event
6%
Clinical Trial
6%
Gastrointestinal Toxicity
5%
Lung Toxicity
5%
